Certara Investor Presentation Deck

The Certara End-to-End Platform Software Tech-driven Services 1. As of 12/31/2021 Discovery 30% of revenue¹ 70% of revenue¹ Preclinical Clinical Across All Drug Types (NDAs and BLAS) Biosimulation Software Platforms © Copyright 2022 Certara, Inc. All rights reserved. Regulatory and Compliance Software Market Access Software Drug Discovery and Development Services with Biosimulation Regulatory Science Post-Approval Market Access For over 20 years, we have purpose-built and invested in our proprietary end-to-end platform with strategic acquisitions and innovation 10 CERTARA

View entire presentation